No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
SYK240719P320000
- 0.65
- -1.05-61.76%
15min DelayClose Jul 5 16:00 ET
0.90High0.65Low
0.90Open1.70Pre Close11 Volume95 Open Interest320.00Strike Price965.00Turnover24.76%IV5.31%PremiumJul 19, 2024Expiry Date0.00Intrinsic Value100Multiplier13DDays to Expiry0.65Extrinsic Value100Contract SizeAmericanOptions Type-0.1228Delta0.0126Gamma337.25Leverage Ratio-0.1147Theta-0.0141Rho-41.43Eff Leverage0.1321Vega
Intraday
- 5D
- Daily
News
Three Reasons to Hold BD (BDX) Stock in Your Portfolio Now
Investors Appear Satisfied With Stryker Corporation's (NYSE:SYK) Prospects
When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") below 16x, you may consider Stryker Corporation (NYSE:SYK) as a stock to avoid entirely with its 37.6x
Merit Medical (MMSI) Inks Deal to Boost Endoscopy Portfolio
Should You Investigate Stryker Corporation (NYSE:SYK) At US$334?
Stryker Is Maintained at Outperform by Evercore ISI Group
Stryker Is Maintained at Outperform by Evercore ISI Group
What 14 Analyst Ratings Have To Say About Stryker
Ratings for Stryker (NYSE:SYK) were provided by 14 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.The following table encapsulates their recent ratings, offeri
Comments
The recent insider sale of Stryker shares at the current price is viewed negatively. However, high insider ownership is seen positively, suggesting management's consideration for shareholders. Yet, the absence of insider buying over the past year is worrisome.
The EPS decline doesn't align with share price changes, indicating other factors. Management might be prioritizing revenue growth over EPS. The company's recent performance improvement suggests potential business momentum.
Read more